Brooktree Capital Management Cardlytics, Inc. Transaction History
Brooktree Capital Management
- $116 Million
- Q2 2024
A detailed history of Brooktree Capital Management transactions in Cardlytics, Inc. stock. As of the latest transaction made, Brooktree Capital Management holds 134,473 shares of CDLX stock, worth $556,718. This represents 0.95% of its overall portfolio holdings.
Number of Shares
134,473
Previous 138,970
3.24%
Holding current value
$556,718
Previous $2.01 Million
45.16%
% of portfolio
0.95%
Previous 1.57%
Shares
10 transactions
Others Institutions Holding CDLX
# of Institutions
143Shares Held
33.9MCall Options Held
946KPut Options Held
1.01M-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.46MShares$26.8 Million4.15% of portfolio
-
Black Rock Inc. New York, NY3.15MShares$13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$9.99 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.17MShares$8.97 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY2.1MShares$8.69 Million1.57% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $136M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...